Georgia Cancer Specialists physician Dr. Janice Galleshaw has recently gained large amounts of media attention for her work in the STAR (Study of Tamoxifen and Raloxifene) trial, for which she served as principle investigator of the Atlanta region. The breast cancer prevention trial was the largest randomized study of its kind, having enrolled 19,747 women at 400 sites in the U.S., Canada, and Puerto Rico.
“This was such an important clinical trial,” said Dr. Galleshaw. “I was happy that I was able to spread the word about the many positives that are associated with this study.”
In recent weeks, Dr. Galleshaw has been interviewed by the Randy & Spiff Morning Show on 94.9 FM; the Community Connection show on 92.9 FM; Atlanta Woman magazine, which has also nominated Dr. Galleshaw for its Woman of the Year Award; and news anchor Karen Greer as a part 11 Alive’s Buddy Check initiative.
The STAR trial concluded that raloxifene, a drug currently used to treat osteoporosis, is just as effective in preventing breast cancer in post-menopausal women as tamoxifen, the current gold standard, and with less side effects.